Physician profile
James Shrouder
NPI 1972865384
$902.88
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $12.67 · 2021: $104 · 2022: $181.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $157.96 | 2019-2022 | |
| Pfizer INC. | $140.51 | 2019 | |
| Amgen INC. | $120.70 | 2019-2022 | |
| Novo Nordisk INC | $99.02 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.02 | 2021-2022 | |
| Abbvie INC. | $48.50 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.48 | 2019 | |
| Esperion Therapeutics, INC. | $28.57 | 2021-2022 | |
| Amarin Pharma, INC. | $26.69 | 2019 | |
| Astellas Pharma US INC | $24.82 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.75 | 2019 | |
| Merck Sharp & Dohme LLC | $14.35 | 2019 | |
| Daiichi Sankyo INC. | $13.97 | 2019 | |
| Genentech USA, INC. | $13.15 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.03 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $12.77 | 2019 | |
| Lilly USA, LLC | $12.67 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.44 | 2019 | |
| Antares Pharma, INC. | $12.43 | 2019 | |
| Ironshore Pharmaceuticals INC. | $11.89 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.31 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Shrouder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.